Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus

Abstract

Get full access to this article

View all access options for this article.

References

Dhote

Simon

Papo

. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003; 49: 633–639.

Uttenthal

Layton

Vyse

Schreiber

. Clinical problem-solving. The wolf at the door. N Engl J Med 2012; 366: 2216–2221.

Balamuth

Nichols

Paessler

Teachey

. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2007; 29: 569–573.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725–1725.

Kumakura

Kondo

Murakawa

. Autoimmune-associated hemophagocytic syndrome (Review article). Mod Rheumatol 2004; 14: 205–215.

Ravelli

. Macrophage activation syndrome. Curr Opin Rheumatol 2002; 14: 548–552.

Deane

Selmi, Teuber

Gershwin

. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010; 153: 109–120.

Sawhney

Woo

Murray

. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 421–426.

Gill

Spencer

Cobcroft

. High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome. Br J Haematol 1994; 88: 204–206.

10.

Wong

Hui

Chan

JKC

Chan

. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991; 114: 387–390.

11.

Botelho

Ferrer

Francisco

Maia

Mendes

Carreira

. Acute lupus hemophagocytic syndrome: report of a case. Nefrologia 2010; 30: 247–251.